305. Effects of moderate spinal cord injury on the expression of a barrier marker in endothelial cells of the testis and in the prostate of rats

2005 ◽  
Vol 17 (9) ◽  
pp. 130
Author(s):  
M. N. Ghabriel ◽  
J. J. Lu ◽  
W. H. Lim ◽  
B. P. Setchell

It was recently shown that the endothelial barrier antigen (EBA), previously thought to be specific to endothelial cells in the central nervous system, was also present in endothelial cells in the testis and in epithelial cells in the dorsolateral prostate of adult rats.1 In the present study, we examined the effect of moderate spinal cord injury (SCI), produced by compression for 5 min of the cord at T 10/11. There was a slight reduction in EBA in the testis and prostate 24 h after SCI, and this became more obvious after 3days. EBA was completely absent from the prostate and testis at 1 week. By 2 and 4 weeks some expression of EBA returned, and at these times EBA was also detected in the ventral prostate. Brain endothelial cells remained positive throughout. We cannot yet say whether these changes are due directly to interference with the nerve supply, or involve changes in androgen status. (1)Ghabriel MN, Lu JJ, Hermanis G, Zhu C, Setchell BP (2002) Reproduction 123, 389–397.

Biomedicines ◽  
2021 ◽  
Vol 9 (6) ◽  
pp. 613
Author(s):  
Katerina Stepankova ◽  
Pavla Jendelova ◽  
Lucia Machova Urdzikova

The spinal cord injury (SCI) is a medical and life-disrupting condition with devastating consequences for the physical, social, and professional welfare of patients, and there is no adequate treatment for it. At the same time, gene therapy has been studied as a promising approach for the treatment of neurological and neurodegenerative disorders by delivering remedial genes to the central nervous system (CNS), of which the spinal cord is a part. For gene therapy, multiple vectors have been introduced, including integrating lentiviral vectors and non-integrating adeno-associated virus (AAV) vectors. AAV vectors are a promising system for transgene delivery into the CNS due to their safety profile as well as long-term gene expression. Gene therapy mediated by AAV vectors shows potential for treating SCI by delivering certain genetic information to specific cell types. This review has focused on a potential treatment of SCI by gene therapy using AAV vectors.


2001 ◽  
Vol 21 (3) ◽  
pp. 188-202 ◽  
Author(s):  
Norman R West ◽  
Victoria LeBlanc ◽  
George H Collins

2013 ◽  
Vol 44 (4) ◽  
pp. 381-390 ◽  
Author(s):  
Debao Li ◽  
Jinlong Zhang ◽  
Wei Huang ◽  
Huricha Jin ◽  
Aiguo Shen ◽  
...  

2007 ◽  
Vol 1147 ◽  
pp. 66-76 ◽  
Author(s):  
Panpan Yu ◽  
Lidong Huang ◽  
Jian Zou ◽  
Huiqing Zhu ◽  
Xiaofei Wang ◽  
...  

2012 ◽  
Vol 29 (3) ◽  
pp. 551-566 ◽  
Author(s):  
Johnny D. Figueroa ◽  
Kathia Cordero ◽  
Keisha Baldeosingh ◽  
Aranza I. Torrado ◽  
Robert L. Walker ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document